MedTrace Logo

Cigarette Smoking in Non-alcoholic Steatohepatitis

NCT04688307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2021-10-21

No results posted yet for this study

Summary

This non-randomized clinical trial was performed to clarify the effect of cigarette smoking reduction on liver function and some anthropocentric indices in smoker patients with non-alcoholic steatohepatitis.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

BEHAVIORAL

Motivational interviewing

Motivational interviewing for smoking reduction and adherence to diet and physical activity for obtaining ideal body weight

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Raika Jamali, MD · TUMS

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-11-01
Completion
2018-12-01

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04688307 on ClinicalTrials.gov